Cover Image

G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xun Sun, Connor Mahler, Natalie D. Stull, Ali Nasiri, Baohua Zhou, Varman Samuel, Gerald Shulman, Jonathan N. Flak, Hongxia Ren
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Obesity
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Insulin Sensitivity in Lean Mass Changes During Weight Loss With or Without Exercise
by: Ciera L. Bartholomew, et al.
Published: (2025)

Retatrutide Shows Multiple Metabolic Benefits in Diet‐Induced Obese MASH Mouse and Hamster Models
by: François Briand, et al.
Published: (2026)

Targeted Next‐Generation Sequencing of the Leptin‐Melanocortin Pathway in Severe Obesity
by: Nathan Faccioli, et al.
Published: (2025)

Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial
by: Eric Baeuerle, et al.
Published: (2026)

Impact of Vertical Sleeve Gastrectomy in Youth‐Onset Type 2 Diabetes: Changes in Glycemia, Insulin Sensitivity, and Secretion
by: Tyler J. Dobbs, et al.
Published: (2026)

Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )
by: John Armato, et al.
Published: (2026)

A Novel Method to Evaluate Insulin Sensitivity by Combining Continuous Glucose Monitoring and Urinary C‐Peptide Excretion
by: Guillermo Sanchez‐Delgado, et al.
Published: (2026)

Aerobic Exercise Plus Hypocaloric Diet on Serum Leptin Concentrations in Adults With Primary Hypertension and Overweight/Obesity: Results From the EXERDIET ‐ HTA Trial
by: Virginia A. Aparicio, et al.
Published: (2026)

Obstructive Sleep Apnea Following Bariatric Surgery: 20 Year Outcomes From the Swedish Obese Subjects Study
by: Ida Arnetorp, et al.
Published: (2026)

Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes
by: Lisa Connery, et al.
Published: (2026)

The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub‐Analysis of an Exploratory Randomised Controlled Trial
by: Ryota Usui, et al.
Published: (2026)

The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long‐Acting Insulin Analogues for Diabetes Mellitus
by: Geremia B. Bolli, et al.
Published: (2026)

Impact of metabolic phenotype changes on the development of chronic kidney disease: Panasonic cohort study 17
by: Junya Hironaka, et al.
Published: (2025)

Microarray Analysis of Visceral Adipose Tissue in Obese Women Reveals Common Crossroads Among Inflammation, Metabolism, Addictive Behaviors, and Cancer
by: Rolando Martínez-Romero, et al.
Published: (2024)

GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
by: Hiba Jebeile, et al.
Published: (2025)

Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
by: Julio Rosenstock, et al.
Published: (2026)

Examining Biomarkers for Dyslipidemia, Diabetes, and NAFLD by CDC's 2022 Extended BMI Percentiles in US Youth Aged 6–17 Years
by: Samantha L. Pierce, et al.
Published: (2025)

Glucocorticoid‐Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most
by: Morton G. Burt, et al.
Published: (2026)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
by: Sheila Pintado-Cucarella
Published: (2016)

Glucagon‐Like Peptide‐1 Receptor Agonists: Considerations for Treating Preconception Obesity
by: Lauren T. Berube, et al.
Published: (2026)

The 1‐Hour Plasma Glucose for Early Risk Stratification in Young, Obese Chinese Adults: Implications for Clinical Management
by: Miaomiao Yuan, et al.
Published: (2026)

Insulin glargine 300 U/ mL safety data in pregnancy
by: Jukka Westerbacka, et al.
Published: (2025)

A New Lens on Childhood Obesity: Developing and Validating the Obesity‐Related Well‐Being (ORWB) Scale for Assessing Well‐Being in Obese Children and Adolescents
by: Jihed Faleh, et al.
Published: (2025)

Brain versus cardiometabolic health: a delicate balance in need of precision lifestyle medicine approaches
by: Jean‐Pierre Després, et al.
Published: (2024)

The Important Role of Phosphatidylserine, ADAM17, TNF‐Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity
by: Chandra Agung Purnama, et al.
Published: (2024)

Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada
by: Xi Zhu, et al.
Published: (2026)

Prevalence and Determinants of Elevated High Sensitivity C‐Reactive Protein Concentrations in Belgian Children and Adolescents With Overweight or Obesity
by: Thomas Mol, et al.
Published: (2025)

Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta‐analysis
by: Min Seo Kim, et al.
Published: (2024)

Adherence and Persistence Among Individuals Living With Type 2 Diabetes and Using a Free Combination of Basal Insulin and an Injectable Glucagon‐Like Peptide‐1 Receptor Agonist Versus a Fixed‐Ratio Combination Therapy: A Japanese Database Study
by: Takeshi Miyatsuka, et al.
Published: (2026)

Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, Canada
by: Youstina Soliman, et al.
Published: (2025)

The Evolving Role of High‐Sensitivity C‐Reactive Protein for Mortality Prediction Across the Spectrum of Cardiovascular–Kidney–Metabolic Syndrome
by: Jing Li, et al.
Published: (2026)

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
by: Jie‐Syuan Wu, et al.
Published: (2026)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes
by: Ying Lu, et al.
Published: (2025)

The Acute Effects of Interrupting Prolonged Sitting With Regular Activity Breaks on Postprandial Glucose and Insulin in Adults: A Systematic Review and Meta‐Analysis
by: Jennifer T. Gale, et al.
Published: (2026)

Weight Changes From Glucagon‐Like Peptide‐1 Receptor Agonist Use and Discontinuation: A Retrospective Cohort Study
by: G. Caleb Alexander, et al.
Published: (2025)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
by: Hao Dai, et al.
Published: (2025)

Dietary Macronutrient Composition and Protein Concentration for Weight Loss Maintenance
by: Hanyue Zhang, et al.
Published: (2025)

Association of Genetic, Environmental, and Nutritional Factors With Metabolic Phenotypes of Obesity: A Scoping Review
by: Haniyeh Danesh Doost, et al.
Published: (2025)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
by: Giorgia Rutigliani, et al.
Published: (2026)

Cost‐Effectiveness of Control‐ IQ + Technology in Insulin‐Treated Patients With Type 2 Diabetes in the United States
by: Neda Al Rawashdh, et al.
Published: (2026)